163 related articles for article (PubMed ID: 8058648)
1. Chemical pathways of peptide degradation. VI. Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides.
Oliyai C; Borchardt RT
Pharm Res; 1994 May; 11(5):751-8. PubMed ID: 8058648
[TBL] [Abstract][Full Text] [Related]
2. Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide.
Oliyai C; Borchardt RT
Pharm Res; 1993 Jan; 10(1):95-102. PubMed ID: 8430066
[TBL] [Abstract][Full Text] [Related]
3. Chemical pathways of peptide degradation. III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides.
Patel K; Borchardt RT
Pharm Res; 1990 Aug; 7(8):787-93. PubMed ID: 2235875
[TBL] [Abstract][Full Text] [Related]
4. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide.
Patel K; Borchardt RT
Pharm Res; 1990 Jul; 7(7):703-11. PubMed ID: 2395797
[TBL] [Abstract][Full Text] [Related]
5. Identification of degradation products of aspartyl tripeptides by capillary electrophoresis-tandem mass spectrometry.
De Boni S; Neusüss C; Pelzing M; Scriba GK
Electrophoresis; 2003 Mar; 24(5):874-82. PubMed ID: 12627450
[TBL] [Abstract][Full Text] [Related]
6. Capillary electrophoretic study of the degradation pathways and kinetics of the aspartyl model tetrapeptide Gly-Phe-Asp-GlyOH in alkaline solution.
Brückner C; Imhof D; Scriba GK
J Pharm Biomed Anal; 2013 Mar; 76():96-103. PubMed ID: 23298912
[TBL] [Abstract][Full Text] [Related]
7. Capillary electrophoresis analysis of hydrolysis, isomerization and enantiomerization of aspartyl model tripeptides in acidic and alkaline solution.
De Boni S; Scriba GK
J Pharm Biomed Anal; 2007 Jan; 43(1):49-56. PubMed ID: 16846713
[TBL] [Abstract][Full Text] [Related]
8. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation.
Geiger T; Clarke S
J Biol Chem; 1987 Jan; 262(2):785-94. PubMed ID: 3805008
[TBL] [Abstract][Full Text] [Related]
9. The effects of a histidine residue on the C-terminal side of an asparaginyl residue on the rate of deamidation using model pentapeptides.
Goolcharran C; Stauffer LL; Cleland JL; Borchardt RT
J Pharm Sci; 2000 Jun; 89(6):818-25. PubMed ID: 10824141
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting cleavage at aspartic residues in model decapeptides.
Li N; Fort F; Kessler K; Wang W
J Pharm Biomed Anal; 2009 Aug; 50(1):73-8. PubMed ID: 19395214
[TBL] [Abstract][Full Text] [Related]
11. The role of the cyclic imide in alternate degradation pathways for asparagine-containing peptides and proteins.
Dehart MP; Anderson BD
J Pharm Sci; 2007 Oct; 96(10):2667-85. PubMed ID: 17518358
[TBL] [Abstract][Full Text] [Related]
12. Effect of conformation on the conversion of cyclo-(1,7)-Gly-Arg-Gly-Asp-Ser-Pro-Asp-Gly-OH to its cyclic imide degradation product.
Bogdanowich-Knipp SJ; Jois SD; Siahaan TJ
J Pept Res; 1999 Jul; 54(1):43-53. PubMed ID: 10448969
[TBL] [Abstract][Full Text] [Related]
13. Effect of adjacent histidine and cysteine residues on the spontaneous degradation of asparaginyl- and aspartyl-containing peptides.
Brennan TV; Clarke S
Int J Pept Protein Res; 1995 Jun; 45(6):547-53. PubMed ID: 7558585
[TBL] [Abstract][Full Text] [Related]
14. Hydrolytic cleavage of pyroglutamyl-peptide bond. II. Effects of amino acid residue neighboring the pGlu moiety.
Saito S; Ohki K; Sakura N; Hashimoto T
Biol Pharm Bull; 1996 May; 19(5):768-70. PubMed ID: 8741593
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of the competitive reactions of isomerization and peptide bond cleavage at l-α- and d-β-aspartyl residues in an αA-crystallin fragment.
Aki K; Okamura E
J Pept Sci; 2017 Jan; 23(1):28-37. PubMed ID: 27905156
[TBL] [Abstract][Full Text] [Related]
16. Chemical pathways of peptide degradation. VII. Solid state chemical instability of an aspartyl residue in a model hexapeptide.
Oliyai C; Patel JP; Carr L; Borchardt RT
Pharm Res; 1994 Jun; 11(6):901-8. PubMed ID: 7937533
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of aspartic acid isomerization and enantiomerization in model aspartyl tripeptides under forced conditions.
Conrad U; Fahr A; Scriba GK
J Pharm Sci; 2010 Oct; 99(10):4162-73. PubMed ID: 20737625
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of stereoisomers and isoforms of a tryptic heptapeptide fragment of human growth hormone and analysis by reverse-phase HPLC and capillary electrophoresis.
Vinther A; Holm A; Høeg-Jensen T; Jespersen AM; Klausen NK; Christensen T; Sørensen HH
Eur J Biochem; 1996 Jan; 235(1-2):304-9. PubMed ID: 8631346
[TBL] [Abstract][Full Text] [Related]
19. Isomerization and epimerization of the aspartyl tetrapeptide Ala-Phe-Asp-GlyOH at pH 10-A CE study.
Brückner C; Bunz SC; Imhof D; Neusüss C; Scriba GK
Electrophoresis; 2013 Sep; 34(18):2666-73. PubMed ID: 23533053
[TBL] [Abstract][Full Text] [Related]
20. Chemical Mimics of Aspartate-Directed Proteases: Predictive and Strictly Specific Hydrolysis of a Globular Protein at Asp-X Sequence Promoted by Polyoxometalate Complexes Rationalized by a Combined Experimental and Theoretical Approach.
Ly HGT; Mihaylov TT; Proost P; Pierloot K; Harvey JN; Parac-Vogt TN
Chemistry; 2019 Nov; 25(63):14370-14381. PubMed ID: 31469197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
